Squalene Rich Leaf RAW
Clean Fractioned PURE
Adjuvant ReadyTODAY
natural adjuvant
natural adjuvant
We produce and supply the highest quality terpene oils such as Tobacco Squalene for the cosmetic and medical sectors. As an adjuvant, the natural squalene molecule plays an essential role in increasing cellular uptake of an antigen in vaccines. It’s the ‘why’ of the response of the immune system to squalene which remains an unknown. Tobacco Squalene is the first of many cutting edge extracts and bio-actives we will launch to replace unsustainable sourcing.
Farm To Pharma
Farm To Pharma
You want the purest plant ingredients in your products. Creating our plants is a time intensive labor of love where we work with the plant’s natural productive capabilities to find new high yield sources of pressurized ingredients. Our squalene is thoroughly purified to pharmaceutical grades with no environmental exposure.
Join Our Journey
Join Our Journey
ScienceCareful breeding
SynShark started with a rebellious idea: to reinvent how science can solve the problems of scarce resources. Working with leading technologists, the Company designed new plant pathways to channel photosynthesis energy towards terpene production, something native to the plant. With designs in hand, we seed and grow continuously indoor tobacco as bio manufacturers of ingredients without any post extraction conversion.
Conservation Saving the Oceans
SynShark only creates oils extracted from renewable plant sources rather than synthetic or animal sources. Squalene as an adjuvant is produced unsustainably from deep-water shark livers, which conveys the risk of associated pollutants and pathogens. By using a plant with known indoor manufacturing for vaccines during pandemics, we displace the needless ‘livering’ of millions of ecologically important sea creatures.
Adjuvant Rapid Response
SynShark’s natural squalene adjuvant ingredient is the only completely biocompatible adjuvant, known to elicit a strong T-Cell response. By all accounts, evidence was available that SARS-CoV-1 immunity relied on T-cell activation and that vaccines should account for this need. Our tobacco squalene adjuvant can be delivered as nanodroplets emulsified by a phospholipid or nonionic surfactant through injection.